SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

AVEOBuy

Aveo Pharmaceuticals Inc

Peter W. Sonsini · 10% owner

$5.0M+21.0%Apr 8
AVEOBuy

Aveo Pharmaceuticals Inc

Scott D Sandell · 10% owner

$5.0M+21.0%Apr 8
AVEOBuy

Aveo Pharmaceuticals Inc

David M Mott · 10% owner

$5.0M+21.0%Apr 8
AVEOBuy

Aveo Pharmaceuticals Inc

Joshua Makower · 10% owner

$5.0M+21.0%Apr 8
AVEOBuy

Aveo Pharmaceuticals Inc

Mohamad Makhzoumi · 10% owner

$5.0M+21.0%Apr 8
AVEOBuy

Aveo Pharmaceuticals Inc

Anthony A. Florence Jr. · 10% owner

$5.0M+21.0%Apr 8
AVEOBuy

Aveo Pharmaceuticals Inc

Forest Baskett · 10% owner

$5.0M+21.0%Apr 8
AVEOBuy

Aveo Pharmaceuticals Inc

Peter J Barris · 10% owner

$5.0M+21.0%Apr 8
AVEOBuy

Aveo Pharmaceuticals Inc

Growth Equity Opportunities Fund Iv, LLC · 10% owner

$5.0M+21.0%Apr 8
AVEOBuy

Aveo Pharmaceuticals Inc

Peter W. Sonsini · 10% owner

$2.2M+6.0%Nov 19
AVEOBuy

Aveo Pharmaceuticals Inc

Scott D Sandell · 10% owner

$2.2M+6.0%Nov 19
AVEOBuy

Aveo Pharmaceuticals Inc

David M Mott · 10% owner

$2.2M+6.0%Nov 19
AVEOBuy

Aveo Pharmaceuticals Inc

Joshua Makower · 10% owner

$2.2M+6.0%Nov 19
AVEOBuy

Aveo Pharmaceuticals Inc

Mohamad Makhzoumi · 10% owner

$2.2M+6.0%Nov 19
AVEOBuy

Aveo Pharmaceuticals Inc

Anthony A. Florence Jr. · 10% owner

$2.2M+6.0%Nov 19
AVEOBuy

Aveo Pharmaceuticals Inc

Forest Baskett · 10% owner

$2.2M+6.0%Nov 19
AVEOBuy

Aveo Pharmaceuticals Inc

Peter J Barris · 10% owner

$2.2M+6.0%Nov 19
AVEOBuy

Aveo Pharmaceuticals Inc

Growth Equity Opportunities Iv, LLC · 10% owner

$2.2M+6.0%Nov 19
AVEOBuy

Aveo Pharmaceuticals Inc

Ravi Viswanathan · 10% owner

$1.5M+4.0%Aug 22
AVEOBuy

Aveo Pharmaceuticals Inc

Peter W. Sonsini · 10% owner

$1.5M+4.0%Aug 22
AVEOBuy

Aveo Pharmaceuticals Inc

Scott D Sandell · 10% owner

$1.5M+4.0%Aug 22
AVEOBuy

Aveo Pharmaceuticals Inc

David M Mott · 10% owner

$1.5M+4.0%Aug 22
AVEOBuy

Aveo Pharmaceuticals Inc

Joshua Makower · 10% owner

$1.5M+4.0%Aug 22
AVEOBuy

Aveo Pharmaceuticals Inc

Mohamad Makhzoumi · 10% owner

$1.5M+4.0%Aug 22
AVEOBuy

Aveo Pharmaceuticals Inc

Anthony A. Florence Jr. · 10% owner

$1.5M+4.0%Aug 22
AVEOBuy

Aveo Pharmaceuticals Inc

Forest Baskett · 10% owner

$1.5M+4.0%Aug 22
AVEOBuy

Aveo Pharmaceuticals Inc

Peter J Barris · 10% owner

$1.5M+4.0%Aug 22
AVEOBuy

Aveo Pharmaceuticals Inc

Growth Equity Opportunities Iv, LLC · 10% owner

$1.5M+4.0%Aug 22
AVEOBuy

Aveo Pharmaceuticals Inc

Ravi Viswanathan · 10% owner

$2.1M+6.0%Apr 10
AVEOBuy

Aveo Pharmaceuticals Inc

Peter W. Sonsini · 10% owner

$2.1M+6.0%Apr 10
AVEOBuy

Aveo Pharmaceuticals Inc

Scott D Sandell · 10% owner

$2.1M+6.0%Apr 10
AVEOBuy

Aveo Pharmaceuticals Inc

Jon Sakoda · 10% owner

$2.1M+6.0%Apr 10
AVEOBuy

Aveo Pharmaceuticals Inc

David M Mott · 10% owner

$2.1M+6.0%Apr 10
AVEOBuy

Aveo Pharmaceuticals Inc

Joshua Makower · 10% owner

$2.1M+6.0%Apr 10
AVEOBuy

Aveo Pharmaceuticals Inc

Anthony A. Florence Jr. · 10% owner

$2.1M+6.0%Apr 10
AVEOBuy

Aveo Pharmaceuticals Inc

Forest Baskett · 10% owner

$2.1M+6.0%Apr 10
AVEOBuy

Aveo Pharmaceuticals Inc

Peter J Barris · 10% owner

$2.1M+6.0%Apr 10
AVEOBuy

Aveo Pharmaceuticals Inc

Growth Equity Opportunities Iv, LLC · 10% owner

$2.1M+6.0%Apr 10
AVEOBuy

Aveo Pharmaceuticals Inc

Ravi Viswanathan · 10% owner

$3.0M+58.0%Mar 29
AVEOBuy

Aveo Pharmaceuticals Inc

Peter W. Sonsini · 10% owner

$3.0M+58.0%Mar 29
AVEOBuy

Aveo Pharmaceuticals Inc

Scott D Sandell · 10% owner

$3.0M+58.0%Mar 29
AVEOBuy

Aveo Pharmaceuticals Inc

Jon Sakoda · 10% owner

$3.0M+58.0%Mar 29
AVEOBuy

Aveo Pharmaceuticals Inc

David M Mott · 10% owner

$3.0M+58.0%Mar 29
AVEOBuy

Aveo Pharmaceuticals Inc

Joshua Makower · 10% owner

$3.0M+58.0%Mar 29
AVEOBuy

Aveo Pharmaceuticals Inc

Anthony A. Florence Jr. · 10% owner

$3.0M+58.0%Mar 29
AVEOBuy

Aveo Pharmaceuticals Inc

Forest Baskett · 10% owner

$3.0M+58.0%Mar 29
AVEOBuy

Aveo Pharmaceuticals Inc

Peter J Barris · 10% owner

$3.0M+58.0%Mar 29
AVEOBuy

Aveo Pharmaceuticals Inc

Growth Equity Opportunities Iv, LLC · 10% owner

$3.0M+58.0%Mar 29

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.